BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4910537)

  • 1. Antigenic determinants of Salmonella for production of "clearance" factor in mouse typhoid.
    Nakano M; Saito K; Toyasaki N
    Jpn J Microbiol; 1970 Mar; 14(2):163-70. PubMed ID: 4910537
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems of anti-typhoid immunity and protective vaccination against typhoid.
    Karolcek J
    Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
    [No Abstract]   [Full Text] [Related]  

  • 3. [Typhoid vaccination from an immunological point of view].
    Günther O
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1970; 65():1-14. PubMed ID: 4926019
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an artificial antigen and immunity to mouse typhoid.
    Jenkin CR; Karnovsky ML; Rowley D
    Immunology; 1967 Oct; 13(4):361-72. PubMed ID: 4861746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemical compositions of the cell wall of Salmonella typhimurium affecting the clearance-rate in mouse; influence of specific antibody.
    Nakano M; Saito K
    Jpn J Microbiol; 1970 Nov; 14(6):451-61. PubMed ID: 4922339
    [No Abstract]   [Full Text] [Related]  

  • 8. Suggested adoption of a non-motile variant of strain Ty 2 for vaccination against typhoid fever.
    Anderson ES
    Prog Immunobiol Stand; 1971; 5():373-7. PubMed ID: 4573944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considerations on the value of some laboratory tests for the evaluation of the effectiveness of the TAB vaccine].
    Chiresco N; Rímniceanu I
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):261-6. PubMed ID: 4961118
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitation of Salmonella O-antibodies in human sera by enzyme-linked immunosorbent assay (ELISA).
    Carlsson HE; Lindberg AA; Hammarström S; Ljunggren A
    Int Arch Allergy Appl Immunol; 1975; 48(4):485-94. PubMed ID: 804453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 12. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 3. CELL-BOUND ANTIBODY.
    ROWLEY D; TURNER KJ; JENKIN CR
    Aust J Exp Biol Med Sci; 1964 Apr; 42():237-48. PubMed ID: 14150758
    [No Abstract]   [Full Text] [Related]  

  • 13. Salmonella-based vaccines.
    Hackett J
    Vaccine; 1990 Feb; 8(1):5-11. PubMed ID: 2180232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent studies on histogenic antibody production and humoral reactivity. III. Antibody response to intracutaneous injection of typhoid vaccine in lipid solution].
    BINAZZI M
    G Ital Dermatol; 1953; 94(6):489-520. PubMed ID: 13162214
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies with artificial antigens and immunity to mouse typhoid. I. Use of O acetylated galactans in the purification of specific antibody against antigen 5.
    Jackson GD; Rowley D; Jenkin CR
    Immunology; 1968 Dec; 15(6):789-98. PubMed ID: 4884961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The experimental basis for several problems in the enteric method of vaccination. I. Immunogenicity of typhoid Vi- and O-antigens in enteric vaccination].
    Kovaleva NI; Khatuntseva NV; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Aug; 45(8):65-71. PubMed ID: 5731442
    [No Abstract]   [Full Text] [Related]  

  • 18. The protective activity of various antigen complexes of typhoid and paratyphoid B vaccines: controlled field trials and laboratory studies.
    Hejfets LB; Levina LA; Bentsianova TG; Salmin LV
    Prog Immunobiol Stand; 1970; 4():561-70. PubMed ID: 4991591
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies and control of oral antityphoid vaccines].
    De Caro M; Samarani E
    Prog Immunobiol Stand; 1970; 4():369-71. PubMed ID: 4921391
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical components in the cell wall of Salmonella typhimurium affecting its virulence and immunogenicity in mice.
    Nakano M; Saito K
    Nature; 1969 Jun; 222(5198):1085-6. PubMed ID: 4891942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.